Scarica l'app Stockscreener
21.88
0.64%
0.14
Dopo l'orario di chiusura:
21.63
-0.25
-1.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Biohaven Ltd Borsa (BHVN) Ultime notizie
Are Smart Investors Making the Right Decision? Biohaven Ltd (BHVN) - Sete News
BHVN’s Market Whiplash: -41.79% YTD Decline, -23.42% Plunge in 30 Days - investchronicle.com
Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo Finance
Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World
Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus
BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Why BioHaven Stock Is Soaring Today - Mitrade
A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com
Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks
Biohaven secures up to $600 million from Oberland Capital - Investing.com
Biohaven Rallies On Heels Of $600M Funding Agreement With OberlandBiohaven (NYSE:BHVN) - Benzinga
Biohaven announces investment of up to $600M - Hartford Business Journal
Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX
Biohaven Announces Investment by Oberland Capital - Contract Pharma
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks
Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com
Why Biohaven Ltd. Shares Are Tumbling - TipRanks
Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize
Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com
Biohaven (BHVN) Price Target Cut by Baird Amid Regulatory Develo - GuruFocus
Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider
Biohaven Lands Massive $600M Backing to Advance First-Ever Treatment for Rare Genetic Disease - Stock Titan
Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World
Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus
Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance
Why Biohaven Stock Plummeted by More Than 15% Today - Yahoo Finance
Biohaven stock slides on withdrawal of European marketing application - BioPharma Dive
Biohaven (BHVN) Withdraws EMA Application, U.S. Approval Crucial - GuruFocus
Biohaven (BHVN) Withdraws Troriluzole Application in Europe, Foc - GuruFocus
Biohaven (BHVN) Stock Drops After Withdrawal of EU Drug Applicat - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Biohaven Ltd. Stock Faces Turbulence Amid Strategic Shifts - TipRanks
Biohaven Ltd (NYSE:BHVN) Shares Surged 25.27% In A Week – But Will They Keep Going Up? - Marketing Sentinel
Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU - Investing.com UK
BHVN’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Biohaven Ltd (BHVN) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com
Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21 - Insider Monkey
Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey
Stock Traders Buy Large Volume of Biohaven Call Options (NYSE:BHVN) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd.BHVN - PR Newswire
Biohaven Ltd (BHVN)’s stock rises to 20.55 per share - uspostnews.com
Biohaven Ltd (NYSE: BHVN) Shocks Wall Street This Week With A 0.88% Stock Price Incline - Marketing Sentinel
Biohaven (BHVN) Options Move Yields 15% Profit in a Day | BHVN S - GuruFocus
Biohaven Pharmaceutical : Announces Pricing Of $250 Million Public Offering Of Common Shares - marketscreener.com
LPL Financial LLC Raises Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Q1 Earnings Estimate for Biohaven Issued By Leerink Partnrs - Defense World
BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm - Finansavisen
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Alliancebernstein L.P. - Defense World
Biohaven Ltd (NYSE: BHVN): One Stock To Trade As Economic Progress Advances - Marketing Sentinel
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Franklin Resources Inc. - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - GlobeNewswire Inc.
Contrasting Biohaven (NYSE:BHVN) & Ampio Pharmaceuticals (NYSE:AMPE) - Defense World
Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients - Benzinga
0.78%
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):